Sage Journals: Discover world-class research

Retricted access

Research article

First published 2020-4

Outcomes of combination therapy with tyrosine kinase inhibitors and immune checkpoint inhibitors in metastatic renal cell carcinoma – A retrospective study

Nadya Jammal, Eva Pan, Michael Hurwitz [...]

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2021

Combination of molecularly targeted therapies and immune checkpoint inhibitors in the new era of unresectable hepatocellular carcinoma treatment

Ze-Long Liu, Jing-Hua Liu, Daniel Staiculescu [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2024

Research progress and future directions of immune checkpoint inhibitor combination therapy in advanced gastric cancer

Puyi He, Long Ma, Bo Xu [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2020

Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model

Chiao-Fang Teng, Ting Wang, Tzu-Hua Wu [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2025-3

Radiation therapy in combination with immune checkpoint inhibitors in metastatic lung cancer: Effect of fractionation

Christopher Rosso, Melissa Reed, Natalie Walde [...]

Journal of Investigative Medicine

Open access

Research article

First published 2024-03

A Systematic Review of Treatment-Related Adverse Events for Combination Therapy of Multiple Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor

Takashi Sawada, Mamoru Narukawa

Cancer Control

Open access

Research article

First published 2019-11-01

Targeted Therapies Following First-Line Immune Checkpoint Inhibitor Combination in Metastatic Renal Cell Carcinoma: A Single Center Experience

Nazli Dizman, Paulo G. Bergerot, Cristiane D. Bergerot [...]

Kidney Cancer

Free access

Review article

First published 2014-9

Therapeutic vaccines as a promising treatment modality against prostate cancer: rationale and recent advances

B. Harpreet Singh, James L. Gulley

Therapeutic Advances in Vaccines and Immunotherapy

Open access

Review article

First published 2022-08-04

What We Have Learnt from CARMENA and SURTIME and What Should Be Done Differently in Future Trials on Cytoreductive Nephrectomy

Patricia J. Zondervan, Axel Bex

Kidney Cancer

Open access

Review article

First published 2022

Evolving landscape of first-line combination therapy in advanced renal cancer: a systematic review

Aly-Khan A. Lalani, Daniel Y. C. Heng, Naveen S. Basappa [...]

Therapeutic Advances in Medical Oncology

Search results